Location: Burlington, VT
CIK: 0001618205 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 13, 2026
Total Value: $171M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| KLAC | KLA CORPORATION | 21,883 | $26.59M | 15.6% | $1215.08 * | $798.69 | +46.7% | COM NEW | 482480100 |
| BMY | BRISTOL-MYERS SQUIBB CO | 302,842 | $16.34M | 9.6% | $53.94 * | $44.70 | +6.3% | COM | 110122108 |
| CMPX | COMPASS THERAPEUTICS INC | 1,592,938 | $8.554M | 5.0% | $5.37 * | $3.82 | +20.9% | COM | 20454B104 |
| STOK | STOKE THERAPEUTICS INC | 260,000 | $8.252M | 4.8% | $31.74 * | $12.13 | +147.9% | COM | 86150R107 |
| LRCX | LAM RESEARCH CORPORATION | 40,329 | $6.904M | 4.0% | $171.18 * | $155.36 | 0.0% | COM NEW | 512807306 |
| OLMA | OLEMA PHARMACEUTICALS INC | 269,000 | $6.725M | 3.9% | $25.00 * | $9.40 | +89.3% | COM | 68062P106 |
| GPCR | STRUCTURE THERAPEUTICS INC | 90,000 | $6.26M | 3.7% | $69.55 | $30.64 | — | SPONS ADR | 86366E106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 55,000 | $4.804M | 2.8% | $87.34 * | $39.90 | +105.1% | COM | 74366E102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 171,000 | $4.567M | 2.7% | $26.71 * | $27.98 | -14.6% | COM | 004225108 |
| OVV | OVINTIV INC | 107,500 | $4.213M | 2.5% | $39.19 | $35.12 | +10.4% | COM | 69047Q102 |
| PRTA | PROTHENA CORP PLC | 441,019 | $4.212M | 2.5% | $9.55 * | $20.83 | -51.1% | SHS | G72800108 |
| SLDB | SOLID BIOSCIENCES INC | 705,955 | $3.982M | 2.3% | $5.64 * | $5.15 | +5.2% | COM NEW | 83422E204 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 27,190 | $3.856M | 2.3% | $141.83 * | $73.35 | +97.5% | COM | 64125C109 |
| FOLD | AMICUS THERAPEUTICS INC | 253,000 | $3.603M | 2.1% | $14.24 * | $7.94 | +23.7% | COM | 03152W109 |
| BCYC | BICYCLE THERAPEUTICS PLC | 462,700 | $3.276M | 1.9% | $7.08 | $7.30 | — | SPONSORED ADS | 088786108 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 195,000 | $3.235M | 1.9% | $16.59 * | $11.94 | +19.6% | COM | 71722W107 |
| CSTL | CASTLE BIOSCIENCES INC | 80,600 | $3.135M | 1.8% | $38.90 * | $23.48 | +37.3% | COM | 14843C105 |
| NTLA | INTELLIA THERAPEUTICS INC | 315,400 | $2.835M | 1.7% | $8.99 * | $12.71 | +8.3% | COM | 45826J105 |
| IMNM | IMMUNOME INC | 130,000 | $2.792M | 1.6% | $21.48 * | $10.60 | +65.5% | COM | 45257U108 |
| CORT | CORCEPT THERAPEUTICS INC | 67,200 | $2.339M | 1.4% | $34.80 * | $14.57 | +439.2% | COM | 218352102 |
| VERA | VERA THERAPEUTICS INC | 44,000 | $2.228M | 1.3% | $50.64 * | $35.52 | 0.0% | CL A | 92337R101 |
| — | QUIDELORTHO CORP | 72,548 | $2.072M | 1.2% | $28.56 | $65.09 | — | COM | 74838J101 |
| NVCR | NOVOCURE LTD | 152,100 | $1.967M | 1.2% | $12.93 | $16.18 | -20.7% | ORD SHS | G6674U108 |
| — | BIODESIX INC | 286,804 | $1.95M | 1.1% | $6.80 | $5.56 | — | COM | 09075X108 |
| CYTK | CYTOKINETICS INC | 30,000 | $1.906M | 1.1% | $63.54 * | $36.48 | +70.5% | COM | 23282W605 |
| PHR | PHREESIA INC | 110,700 | $1.873M | 1.1% | $16.92 * | $21.44 | -3.8% | COM | 71944F106 |
| EQT | EQT CORPORATION | 34,619 | $1.856M | 1.1% | $53.60 * | $33.40 | +68.1% | COM | 26884L109 |
| HROW | HARROW HEALTH INC | 34,000 | $1.666M | 1.0% | $49.00 * | $6.05 | +594.4% | COM | 415858109 |
| TVTX | TRAVERE THERAPEUTICS INC | 43,000 | $1.643M | 1.0% | $38.21 * | $13.34 | +143.7% | COM | 89422G107 |
| FHTX | FOGHORN THERAPEUTICS INC | 281,730 | $1.521M | 0.9% | $5.40 * | $16.56 | -72.6% | COM | 344174107 |
| UTHR | UNITED THERAPEUTICS CORP | 3,000 | $1.462M | 0.9% | $487.25 * | $93.09 | +400.3% | COM | 91307C102 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 62,000 | $1.426M | 0.8% | $23.00 * | $37.12 | -11.4% | COM | 90400D108 |
| ALKS | ALKERMES PLC | 50,000 | $1.399M | 0.8% | $27.98 * | $21.00 | +42.6% | SHS | G01767105 |
| NKTR | NEKTAR THERAPEUTICS | 31,000 | $1.311M | 0.8% | $42.28 * | $53.00 | +5.6% | COM | 640268306 |
| APGE | APOGEE THERAPEUTICS INC | 16,000 | $1.208M | 0.7% | $75.48 * | $38.35 | +64.2% | COM | 03770N101 |
| VSTM | VERASTEM INC | 150,000 | $1.158M | 0.7% | $7.72 * | $8.91 | 0.0% | COM NEW | 92337C203 |
| AXSM | AXSOME THERAPEUTICS INC | 6,061 | $1.107M | 0.6% | $182.64 * | $94.39 | +47.9% | COM | 05464T104 |
| MASI | MASIMO CORP | 8,280 | $1.077M | 0.6% | $130.06 * | $81.54 | +75.6% | COM | 574795100 |
| TXG | 10X GENOMICS INC | 59,000 | $962K | 0.6% | $16.31 * | $15.11 | 0.0% | COM | 88025U109 |
| XENE | XENON PHARMACEUTICALS INC | 21,000 | $941K | 0.6% | $44.82 * | $34.29 | +22.5% | COM | 98420N105 |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 500,000 | $935K | 0.5% | $1.87 * | $1.19 | +60.9% | COM | 69404D108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 57,000 | $921K | 0.5% | $16.15 * | $15.61 | -15.2% | COM | 483497103 |
| FCX | FREEPORT-MCMORAN CL-B | 18,046 | $917K | 0.5% | $50.79 * | $37.70 | +14.9% | CL-B | 35671D857 |
| VTYX | VENTYX BIOSCIENCES INC | 100,827 | $910K | 0.5% | $9.03 * | $8.08 | -7.5% | COM | 92332V107 |
| PHVS | PHARVARIS N V | 29,847 | $828K | 0.5% | $27.75 * | $23.14 | +4.1% | COM | N69605108 |
| ILMN | ILLUMINA INC | 6,000 | $787K | 0.5% | $131.16 * | $117.40 | 0.0% | COM | 452327109 |
| QURE | UNIQURE NV | 30,789 | $737K | 0.4% | $23.93 * | $12.44 | +210.1% | SHS | N90064101 |
| HALO | HALOZYME THERAPEUTICS INC | 10,100 | $680K | 0.4% | $67.30 | $51.35 | +31.0% | COM | 40637H109 |
| — | BIOHAVEN LTD | 59,365 | $670K | 0.4% | $11.29 | $11.29 | — | COM | G11196105 |
| BBIO | BRIDGEBIO PHARMA INC | 8,688 | $665K | 0.4% | $76.49 * | $41.64 | +57.7% | COM | 10806X102 |
| TMCI | TREACE MEDICAL CONCEPTS INC | 226,947 | $556K | 0.3% | $2.45 * | $6.12 | -29.0% | COM | 89455T109 |
| LUNG | PULMONX CORP | 250,573 | $554K | 0.3% | $2.21 * | $1.88 | 0.0% | COM | 745848101 |
| RAPT | RAPT THERAPEUTICS INC | 15,000 | $508K | 0.3% | $33.87 * | $31.06 | 0.0% | COM NEW | 75382E208 |
| GOSS | GOSSAMER BIO INC | 138,176 | $428K | 0.3% | $3.10 * | $5.35 | -46.7% | COM | 38341P102 |
| ATEC | ALPHATEC HOLDINGS INC | 18,058 | $380K | 0.2% | $21.04 * | $8.72 | +112.2% | COM | 02081G201 |
| — | OUTSET MEDICAL INC | 98,913 | $367K | 0.2% | $3.71 | $9.28 | — | COM | 690145107 |
| APLS | APELLIS PHARMACEUTICALS INC | 14,000 | $352K | 0.2% | $25.12 * | $39.43 | -40.5% | COM | 03753U106 |
| LQDA | LIQUIDIA TECHNOLOGIES INC | 10,000 | $345K | 0.2% | $34.49 * | $28.47 | 0.0% | COM | 53635D202 |
| CADL | CANDEL THERAPEUTICS INC | 60,000 | $339K | 0.2% | $5.65 * | $5.91 | -8.9% | COM | 137404109 |
| VYGR | VOYAGER THERAPEUTICS INC | 74,918 | $294K | 0.2% | $3.93 | $4.67 | — | COM | 92915B106 |
| TRIN | TRINITY CAP INC | 20,000 | $293K | 0.2% | $14.65 * | $14.09 | 0.0% | COM | 896442308 |
| INBX | INHIBRX BIOSCIENCES INC | 3,698 | $292K | 0.2% | $79.00 * | $14.64 | +365.3% | COM | 45720N103 |
| KBDC | KAYNE ANDERSON BDC INC | 20,000 | $286K | 0.2% | $14.32 | $14.18 | 0.0% | COM SHS | 48662X105 |
| CGEM | CULLINAN THERAPEUTICS INC | 20,000 | $207K | 0.1% | $10.35 * | $40.60 | -77.8% | COM | 230031106 |
| ELUT | ELUTIA INC | 263,018 | $182K | 0.1% | $0.69 * | $5.84 | -87.0% | COM | 05479K106 |
| ALMS | ALUMIS INC | 10,000 | $97,600 | 0.1% | $9.76 * | $12.13 | -42.4% | COM | 022307102 |
| DCGO | DOCGO INC | 49,908 | $43,809 | 0.0% | $0.88 * | $4.44 | -76.0% | COM | 256086109 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 17,000 | $22,950 | 0.0% | $1.35 * | $13.92 | -89.5% | COM | 98943L107 |